These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 25744488)
1. Reference values of IGF1, IGFBP3 and IGF1/IGFBP3 ratio in adult population in the Czech Republic. Kucera R; Topolcan O; Pecen L; Kinkorova J; Svobodova S; Windrichova J; Fuchsova R Clin Chim Acta; 2015 Apr; 444():271-7. PubMed ID: 25744488 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study. Adachi Y; Nojima M; Mori M; Matsunaga Y; Akutsu N; Sasaki S; Endo T; Kurozawa Y; Wakai K; Tamakoshi A; Tumour Biol; 2016 Nov; 37(11):15125-15132. PubMed ID: 27662841 [TBL] [Abstract][Full Text] [Related]
3. Spontaneous growth hormone secretion and IGF1:IGFBP3 molar ratios in children born small for gestational age (SGA). Völkl TM; Schwöbel K; Simm D; Beier C; Rohrer TR; Dörr HG Growth Horm IGF Res; 2004 Dec; 14(6):455-61. PubMed ID: 15519254 [TBL] [Abstract][Full Text] [Related]
4. ω-3 fatty acid differentially modulated serum levels of IGF1 and IGFBP3 in men with CVD: a randomized, double-blind placebo-controlled study. Gholamhosseini S; Nematipour E; Djazayery A; Javanbakht MH; Koohdani F; Zareei M; Djalali M Nutrition; 2015 Mar; 31(3):480-4. PubMed ID: 25701338 [TBL] [Abstract][Full Text] [Related]
5. Cross-sectional and longitudinal relation of IGF1 and IGF-binding protein 3 with lipid metabolism. Eggert ML; Wallaschofski H; Grotevendt A; Nauck M; Völzke H; Samietz S; Friedrich N Eur J Endocrinol; 2014 Jul; 171(1):9-19. PubMed ID: 24743393 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of bioactive IGF1 and physiological markers of ageing in healthy adults. Vestergaard PF; Hansen M; Frystyk J; Espelund U; Christiansen JS; Jørgensen JO; Fisker S Eur J Endocrinol; 2014 Feb; 170(2):229-36. PubMed ID: 24179101 [TBL] [Abstract][Full Text] [Related]
7. Circulating IGF1 and IGFBP3 in relation to the development of β-cell autoimmunity in young children. Peet A; Hämäläinen AM; Kool P; Ilonen J; Knip M; Tillmann V; Eur J Endocrinol; 2015 Aug; 173(2):129-37. PubMed ID: 25947142 [TBL] [Abstract][Full Text] [Related]
8. Circulating levels of IGF1 are associated with muscle strength in middle-aged- and oldest-old women. Taekema DG; Ling CH; Blauw GJ; Meskers CG; Westendorp RG; de Craen AJ; Maier AB Eur J Endocrinol; 2011 Feb; 164(2):189-96. PubMed ID: 21135066 [TBL] [Abstract][Full Text] [Related]
9. Effect of Zinc Supplementation on GH, IGF1, IGFBP3, OCN, and ALP in Non-Zinc-Deficient Children. Rocha ÉD; de Brito NJ; Dantas MM; Silva Ade A; Almeida Md; Brandão-Neto J J Am Coll Nutr; 2015; 34(4):290-9. PubMed ID: 25759961 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of IGF1 and IGFBP3 during diet therapy in patients with food allergy with complex nutritional risk]. La Grutta S; Maggio C; Giuffrè M; Carta M; Teresi S; Liotta A Minerva Pediatr; 1996; 48(7-8):303-7. PubMed ID: 8965761 [TBL] [Abstract][Full Text] [Related]
11. Insulin-Like Growth Factor 1 Related to Chronic Low-Grade Inflammation in Patients with Obesity and Early Change of its Levels After Laparoscopic Sleeve Gastrectomy. Wang X; Sun H; Ma B; Gao J; Yin J; Qu S Obes Surg; 2020 Sep; 30(9):3326-3332. PubMed ID: 32410151 [TBL] [Abstract][Full Text] [Related]
12. IGF1 and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men. Yeap BB; Chubb SA; Ho KK; Setoh JW; McCaul KA; Norman PE; Jamrozik K; Flicker L Eur J Endocrinol; 2010 Feb; 162(2):249-57. PubMed ID: 19917654 [TBL] [Abstract][Full Text] [Related]
13. Associations of IGF1 and its binding proteins with abdominal aortic aneurysm and aortic diameter in older men. Yeap BB; Chubb SA; McCaul KA; Flicker L; Ho KK; Golledge J; Hankey GJ; Norman PE Eur J Endocrinol; 2012 Feb; 166(2):191-7. PubMed ID: 22113073 [TBL] [Abstract][Full Text] [Related]
14. Association of serum IGF1 with endothelial function: results from the population-based study of health in Pomerania. Empen K; Lorbeer R; Völzke H; Robinson DM; Friedrich N; Krebs A; Nauck M; Reffelmann T; Ewert R; Felix SB; Wallaschofski H; Dörr M Eur J Endocrinol; 2010 Oct; 163(4):617-23. PubMed ID: 20651065 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of IGF1/IGFBP3 Molar Ratio as an Effective Tool for Assessing the Safety of Growth Hormone Therapy in Small-for-gestational-age, Growth Hormone-Deficient and Prader-Willi Children. Gaddas M; Périn L; Le Bouc Y J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):253-261. PubMed ID: 30759961 [TBL] [Abstract][Full Text] [Related]
16. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136 [TBL] [Abstract][Full Text] [Related]
17. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like Growth Factor-1, Insulin-like Growth Factor Binding Protein-3 and the Incidence of Malignant Neoplasms in a Nested Case-Control Study. Adachi Y; Nojima M; Mori M; Himori R; Kubo T; Yamano HO; Lin Y; Wakai K; Tamakoshi A; Cancer Prev Res (Phila); 2020 Apr; 13(4):385-394. PubMed ID: 31996369 [TBL] [Abstract][Full Text] [Related]
19. Associations of plasma IGF1, IGFBP3 and estradiol with leucocyte telomere length, a marker of biological age, in men. Yeap BB; Hui J; Knuiman MW; S A Paul C; Ken K Y H; Flicker L; Divitini ML; Arscott GM; Twigg SM; Almeida OP; Hankey GJ; Golledge J; Beilby JP Eur J Endocrinol; 2020 Jan; 182(1):23-33. PubMed ID: 31658437 [TBL] [Abstract][Full Text] [Related]
20. Growth factors and breast tumors, comparison of selected growth factors with traditional tumor markers. Kucera R; Cerna M; Narsanska A; Svobodova S; Strakova M; Vrzalova J; Fuchsova R; Treskova I; Kydlicek T; Treska V; Pecen L; Topolcan O; Pazdiora P Anticancer Res; 2011 Dec; 31(12):4653-6. PubMed ID: 22199345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]